Featured publications

• Overall Quality of Care Predicts the Variability of Key Risk Factors for Complications in Type 2 Diabetes: An Observational, Longitudinal Retrospective Study

  Authors: Ceriello A, Rossi MC, De Cosmo S, Lucisano G, Pontremoli R, Fioretto P, Giorda C, Pacilli A, Viazzi F, Russo G, Nicolucci A, AMD-Annals Study Group.

  Reference: DIABETES CARE 2019; 42(4):514-519.

• Glycaemic variability in diabetes: clinical and therapeutic implications.

  Authors: Ceriello A, Monnier L, Owens D.

  Reference: Lancet Diabetes & Endocrinology 2019; 7(3):221-230.

• Obesity-associated exosomal miRNAs modulate glucose and lipid metabolism in mice

  Authors: Castaño C, Kalko S, Novials A, Párrizas M.

  Reference: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2018; 115(48):12158-12163.

• Pancreatic β cells overexpressing hIAPP impaired mitophagy and unbalanced mitochondrial dynamics

  Authors: Hernández M; Aguilar A; Burillo J; Oca R; Manca M; Novials A; Alcarraz-Vizan G; Guillén C; Benito M.

  Reference: Cell Death & Disease 2018; 9(5):481-.

• Stress-Induced MicroRNA-708 Impairs β-Cell Function and Growth.

  Authors: Rodríguez-Comas J, Moreno-Asso A, Moreno-Vedia J, Martín M, Castaño C, Marzà-Florensa A, Bofill-De Ros X, Mir-Coll J, Montané J, Fillat C, Gasa R, Novials A, Servitja JM.

  Reference: DIABETES 2017; 66(12):3029-3040.

• BACE2 suppression promotes β-cell survival and function in a model of type 2 diabetes induced by human islet amyloid polypeptide overexpression.

  Authors: Alcarraz-Vizán G, Castaño C, Visa M, Montane J, Servitja JM, Novials A.

  Reference: CELLULAR AND MOLECULAR LIFE SCIENCES 2017; 74(15):2827-2838.

• Mitochondrial Dynamics Mediated by Mitofusin 1 Is Required for POMC Neuron Glucose-Sensing and Insulin Release Control.

  Authors: Ramírez S, Gómez-Valadés AG, Schneeberger M, Varela L, Haddad-Tóvolli R, Altirriba J, Noguera E, Drougard A, Flores-Martínez Á, Imbernón M, Chivite I, Pozo M, Vidal-Itriago A, Garcia A, Cervantes S, Gasa R, Nogueiras R, Gama-Pérez P, Garcia-Roves PM, Cano DA, Knauf C, Servitja JM, Horvath TL, Gomis R, Zorzano A, Claret M.

  Reference: Cell Metabolism 2017; 25(6):1390-1399.

• Amyloid-induced beta-cell dysfunction and islet inflammation are ameliorated by 4-phenylbutyrate (PBA) treatment

  Authors: Montane, Joel; de Pablo, Sara; Castano, Carlos; Rodriguez-Comas, Julia; Cadavez, Lisa; Obach, Merce; Visa, Montse; Alcarraz-Vizan, Gema; Sanchez-Martinez, Melchor; Nonell-Canals, Alfons; Parrizas, Marcelina; Servitja, Joan-Marc; Novials, Anna.

  Reference: FASEB JOURNAL 2017; 31(12):5296-5306.

• Islet amyloid polypeptide exerts a novel autocrine action in b-cell signaling and proliferation

  Authors: Visa M., Alcarraz-Vi?an G., Montane J., Cadavez L., Castaño C., Villanueva-Peñacarrillo M., Servitja J., Novials A..

  Reference: FASEB JOURNAL 2015; 29(7):2970-2979.

• Simultaneous GLP-1 and insulin administration acutely enhances their vasodilatory, antiinflammatory, and antioxidant action in type 2 diabetes.

  Authors: Ceriello A, Novials A, Canivell S, La Sala L, Pujadas G, Esposito K, Testa R, Bucciarelli L, Rondinelli M, Genovese S.

  Reference: DIABETES CARE 2014; 37(7):1938-1943.